CD4 Cell Counts的临床试验
总计61617个结果
-
National Institute of Allergy and Infectious Diseases...终止
-
National Institute of Allergy and Infectious Diseases...完全的
-
National Institute of Allergy and Infectious Diseases...招聘中
-
Instituto Nacional de Ciencias Medicas y Nutricion...暂停
-
National Institute of Allergy and Infectious Diseases...招聘中
-
Imperial College London撤销
-
Medical University of Warsaw尚未招聘艾滋病病毒 | 艾滋病 | 艺术 | 治疗抵抗性疾病 | CD4 缺乏症 | 治疗敏感的 HIV 感染
-
Centre Hospitalier du Centre du ValaisUniversity of Lausanne Hospitals; Research Unit CHCVs Hôpital de Sion Switzerland; Immunology...未知
-
National Institute of Allergy and Infectious Diseases...招聘中
-
Jena University HospitalUniversity of Leipzig; Technische Universität Dresden; University of Magdeburg; University of Rostock 和其他合作者完全的
-
National Institute of Allergy and Infectious Diseases...NeoImmune Tech尚未招聘
-
The First Affiliated Hospital with Nanjing Medical...Nanjing Legend Biotechnology Co. The First Affiliated Hospital of USTC west district;The First...终止
-
Bamrasnaradura Infectious Diseases InstituteThai Red Cross AIDS Research Centre; Clinical Research Collaborative Network完全的Effectiveness of Efavirenz-based Regimen in HIV-1-infected Patients With Nevirapine HypersensitivityTreatment Failure, HIV or AIDS | CD4 Cell Counts泰国
-
Zhejiang UniversityYake Biotechnology Ltd.招聘中
-
Statens Serum InstitutEuropean and Developing Countries Clinical Trials Partnership (EDCTP); Ministry of the Interior...完全的
-
University of Illinois at Chicago撤销
-
University of PennsylvaniaInternational Foundation for CDKL5 Research; Loulou Foundation; CDKL5 Alliance招聘中
-
Masonic Cancer Center, University of Minnesota撤销
-
Dren BioNovotech招聘中侵袭性 NK 细胞白血病 | 肝脾T细胞淋巴瘤 | 肠病相关的T细胞淋巴瘤 | 皮下脂膜炎样 T 细胞淋巴瘤 | 单形性趋上皮性肠 T 细胞淋巴瘤 | LGLL - 大颗粒淋巴细胞白血病 | 原发性皮肤 T 细胞淋巴瘤 - 类别 | 原发性皮肤 CD8 阳性侵袭性嗜表皮 T 细胞淋巴瘤 | 系统性 EBV1 T 细胞淋巴瘤,如果 CD8 阳性 | Hydroa Vacciniforme-Like Lymphoproliferative Disorder | 结外 NK/T 细胞淋巴瘤,鼻型 | 胃肠道惰性慢性淋巴增生性疾病 (CLPD)(CD8+ 或 NK 衍生) | 上面未列出的其他 CD8+/NK 细胞驱动的淋巴瘤美国, 澳大利亚, 法国, 西班牙
-
Mayo ClinicChildren's Hospital of Philadelphia; Seattle Children's Hospital终止
-
Eva Morava-Kozicz尚未招聘
-
Eva Morava-Kozicz尚未招聘
-
Finch Research and Development LLC.Medpace, Inc.完全的艰难梭菌感染 | 复发性艰难梭菌感染 | C.差异 | CDI | 复发性 C. 差异 | rCDI | C.艰难 | 复发性 CDI | 裂变材料 | 粪便微生物群 | 粪便移植美国, 加拿大
-
Hebei Senlang Biotechnology Inc., Ltd.主动,不招人用于 CD7+ T 细胞淋巴母细胞白血病或 T 细胞淋巴母细胞淋巴瘤的 SenL-T7 CAR T 细胞中国
-
Huazhong University of Science and TechnologyShanghai IASO Biotechnology Co., Ltd尚未招聘慢性淋巴细胞白血病 (CLL) | 外周 T 细胞淋巴瘤 (PTCL) | CD5+ 复发/难治性造血系统恶性肿瘤 | 套细胞淋巴瘤 (MCL) | 弥漫性大 B 细胞淋巴瘤 (DLBCL) | 滤泡性淋巴瘤 (FL)
-
Maggie's Pearl, LLC主动,不招人Pmm2-CDG | 磷酸甘露糖变位酶 2 缺乏症 | 磷酸甘露糖变位酶 2 先天性糖基化障碍 | 磷酸甘露糖变位酶 II 先天性糖基化障碍 | 磷酸甘露糖变位酶 II 缺乏症美国
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Peking University People's Hospital; The First Affiliated Hospital of Zhengzhou University; Zhejiang... 和其他合作者招聘中
-
Memorial Sloan Kettering Cancer Center完全的CD34 Selected Peripheral Blood Stem Cell Graft美国
-
Hunan Cancer Hospital尚未招聘乳腺癌 | 内分泌治疗 | CDK4/6 抑制剂 | 后续治疗
-
Hospital Ruber Internacional招聘中
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人复发性套细胞淋巴瘤 | CD20阳性 | 难治性套细胞淋巴瘤 | 胚细胞变异套细胞淋巴瘤 | CCND1 蛋白过表达 | CD5阳性 | FCER2 阴性 | 多形性变异套细胞淋巴瘤 | t(11;14)(q13;q32)美国
-
University of Wisconsin, MadisonAgency for Healthcare Research and Quality (AHRQ)完全的
-
AstraZeneca主动,不招人第 1 部分:晚期 B 细胞恶性肿瘤 | 第 2 部分:r/rCLL 和 r/rMCL | 第 3 部分:未经治疗的 CLL日本
-
Zhejiang Cancer Hospital招聘中晚期 HR 阳性和 HER2 阴性乳腺癌; CDK4/6抑制剂治疗失败中国
-
University of California, Los AngelesCenters for Disease Control and Prevention完全的免疫状态 | Well 托儿所参观
-
ImmuniMed Inc.University of Manitoba; University of Calgary招聘中